Sphinx Scientific Co., Ltd (Tianjin) is a one-stop CDMO service company engaged in the research, development and production of RSM for the new drug development in China. With more than ten years of experience in technical development and perfection when carrying out thousands of projects, the company can help optimize and improve the technical process originally provided by customers. We carry out process development by focusing on product quality and deliver products to customers with guaranteed quality and quantity. Sphinx also cooperates with and assists its customers in their new drug applications. For projects that only have lead compound structures with no other technical details available, the company can quickly explore and develop technical routes suitable for scale-up production. Currently, the company has in-depth cooperation with more than one hundred new drug development companies in China, and has completed hundreds of R&D projects for of RSM production for either toxicological approval or commercialization. The company possesses many new and leading technologies and has rich experience in the fields of asymmetric synthesis, aliphatic ring construction, continuous reaction, photoreaction and biological enzyme synthesis. Built upon technical innovation, the company has continuously applied its unique core technologies in many challenging projects.

Founded in December 2009, the company is headquartered in the Tianjin Economic and Technological Development Zone (TEDA), which is the core functional area of Binhai New Area, Tianjin. It boasts an R&D center of more than 16,000 square meters, and is fully equipped with all the necessary facilities including a hazardous chemical warehouse and a wastewater treatment station. In addition, the company has three other facilities in Panjin in Liaoning, Baotou in Inner Mongolia and Huairen in Shanxi, covering a total area of about 35 acres. These production facilities can accommodate manufacturing processes from small scale test to large-up commercial production. Customized production line is also available when needed by the customer. At present, seven RSM commercialization projects for new drug registration have been successfully launched into production.

RSM is the cornerstone to secure the production and supply of drugs. A green and safe production of RSMs is an important part of the green and safe drug production.

It is our belief that responsibility will not stop at delivery and innovation is a never ending endeavor. Continuous optimization is the main theme of every project awarded to Sphinx.

Always keeping our mission and key value in mind, Sphinx is committed to greener and safer processes. Spinx will continue to help facilitate new drug evelopement in China and around the world.